D.I.NONI PLUS COMBINATION PRODUCT TEA LEAF

Indications

• Antioxidant support
• Anti-inflammatory effects
• Immune system enhancement
• Potential adjunctive treatment in cancer therapy
• Pain relief
• Digestive health

Dosage

Children: Refer to specific product guidelines, as dosages can vary widely depending on the formulation.

Adults: Refer to specific product guidelines, as dosages can vary widely depending on the formulation.

Mechanism of action

The active compounds in noni, including iridoids, anthraquinones, and various vitamins and minerals, exert their effects through multiple pathways. Iridoids, such as damnacanthal, are believed to have anti-inflammatory and analgesic properties by inhibiting pro-inflammatory mediators. Additionally, noni has been shown to enhance immune function and promote the production of cytokines, contributing to its purported health benefits.

Pharmacodynamics

Noni exhibits a range of pharmacodynamic effects, primarily attributed to its antioxidant capacity, which helps to neutralize free radicals and reduce oxidative stress. Its anti-inflammatory properties are also significant, as they can help alleviate conditions associated with chronic inflammation. The modulation of immune responses is another critical aspect of noni's pharmacodynamics, potentially aiding in the body's ability to fight infections and disease.

Pharmacokinetics

The pharmacokinetics of noni are not extensively characterized in the literature. However, it is known that the bioactive compounds in noni are absorbed through the gastrointestinal tract. Factors such as the formulation (juice vs extract) and individual metabolism may influence the extent of absorption and the overall bioavailability of its active constituents. Further studies are required to elucidate the specific pharmacokinetic profiles of noni compounds.

Adverse effects

• Nausea
• Diarrhea
• Abdominal discomfort
• Headache
• Dizziness

Interactions

• May interact with anticoagulants and antiplatelet medications, increasing the risk of bleeding
• Potential interaction with antihypertensive drugs, which may enhance their effects

Precautions

• Use with caution in individuals with liver disease
• Should be used under medical supervision in patients on other medications

Pregnancy

Limited data is available on the safety of noni during pregnancy. Consult a healthcare provider before use.

Breast-feeding

Limited data is available on the safety of noni during breastfeeding. Consult a healthcare provider before use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Noni juice
• Noni capsules
• Noni powder

Indications

• Allergic rhinitis
• Common cold
• Sinusitis
• Nasal congestion
• Cough associated with colds or allergies

Dosage

Children: Refer to B

Adults: Refer to specific product guidelines for dosing; generally taken every 4 to 6 hours as needed, not exceeding the maximum daily limit.

Mechanism of action

The active components in Plus work synergistically to relieve symptoms. Antihistamines block the action of histamine at H1 receptors, reducing allergy symptoms such as sneezing and runny nose. Decongestants act on alpha-adrenergic receptors in the nasal mucosa, leading to vasoconstriction and reduced edema, thereby relieving nasal congestion. If an analgesic or antipyretic is included, it typically works by inhibiting cyclooxygenase enzymes, leading to decreased production of prostaglandins, which are mediators of pain and fever.

Pharmacodynamics

The pharmacodynamic effects of Plus vary based on its specific formulation. Antihistamines provide symptomatic relief from allergic reactions, while decongestants improve airflow through the nasal passages. The analgesic component, if present, helps in reducing pain and fever, enhancing overall comfort during illness. The onset of action varies with the route of administration, generally occurring within 30 minutes to an hour after oral intake.

Pharmacokinetics

The pharmacokinetics of Plus depend on its individual components. Generally, antihistamines are well absorbed from the gastrointestinal tract, with peak plasma concentrations occurring within 1 to 3 hours. They undergo hepatic metabolism and are eliminated primarily through the urine. Decongestants also have good oral bioavailability, with a similar onset of action. Their elimination half-lives vary, ranging from 2 to 12 hours. If analgesic components are present, they may have longer half-lives and specific metabolic pathways.